Yousif Capital Management LLC Has $1.28 Million Stake in Exponent, Inc. $EXPO

Yousif Capital Management LLC trimmed its stake in Exponent, Inc. (NASDAQ:EXPO) by 1.8% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,139 shares of the business services provider’s stock after selling 306 shares during the period. Yousif Capital Management LLC’s holdings in Exponent were worth $1,280,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Envestnet Asset Management Inc. increased its holdings in Exponent by 2.0% in the first quarter. Envestnet Asset Management Inc. now owns 441,646 shares of the business services provider’s stock valued at $35,800,000 after purchasing an additional 8,501 shares during the period. Entropy Technologies LP acquired a new stake in Exponent in the first quarter valued at $547,000. Bessemer Group Inc. increased its holdings in Exponent by 103.3% in the first quarter. Bessemer Group Inc. now owns 681 shares of the business services provider’s stock valued at $55,000 after purchasing an additional 346 shares during the period. Martin Currie Ltd. acquired a new stake in Exponent in the first quarter valued at $450,000. Finally, Principal Financial Group Inc. increased its holdings in Exponent by 1.0% in the first quarter. Principal Financial Group Inc. now owns 133,498 shares of the business services provider’s stock valued at $10,821,000 after purchasing an additional 1,297 shares during the period. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “hold (c-)” rating on shares of Exponent in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Exponent Trading Up 2.3%

Shares of Exponent stock opened at $69.06 on Tuesday. The business has a 50-day moving average price of $69.56 and a two-hundred day moving average price of $73.66. Exponent, Inc. has a 1-year low of $63.81 and a 1-year high of $112.75. The company has a market cap of $3.49 billion, a P/E ratio of 34.53 and a beta of 0.91.

Exponent (NASDAQ:EXPO) last issued its quarterly earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.04. The firm had revenue of $132.87 million during the quarter, compared to the consensus estimate of $130.82 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The business’s revenue was up 7.3% compared to the same quarter last year. During the same period last year, the business posted $0.57 EPS. Equities research analysts forecast that Exponent, Inc. will post 1.98 EPS for the current fiscal year.

Exponent Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Friday, September 5th were issued a $0.30 dividend. The ex-dividend date was Friday, September 5th. This represents a $1.20 annualized dividend and a yield of 1.7%. Exponent’s dividend payout ratio is presently 60.00%.

Insider Activity at Exponent

In other Exponent news, VP Joseph Sala sold 1,595 shares of the stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total value of $112,670.80. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Catherine Corrigan sold 4,930 shares of the stock in a transaction that occurred on Wednesday, October 15th. The stock was sold at an average price of $66.82, for a total value of $329,422.60. Following the completion of the transaction, the chief executive officer owned 82,753 shares in the company, valued at approximately $5,529,555.46. The trade was a 5.62% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 16,326 shares of company stock worth $1,133,059. Corporate insiders own 1.60% of the company’s stock.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.